ARKANSAS CHILDRENS HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.7M
- Transactions
- 418
- Companies
- 40
- Average per transaction
- $4,077
Who reported the payments
| Amgen | $415,241 |
| Takeda Pharmaceuticals U.S.A., Inc. | $266,016 |
| Jazz Pharmaceuticals Inc. | $127,030 |
| B. Braun Medical Inc. | $123,133 |
| Immedica Pharma US, Inc. | $101,511 |
| E.r. Squibb & Sons, L.L.C. | $94,418 |
| Grace Medical, Inc. | $64,194 |
| Pfizer | $62,620 |
| Merck | $61,698 |
| Stryker | $48,564 |
| UCB GmbH | $46,623 |
| Hikma Pharmaceuticals USA | $31,495 |
| Tandem Diabetes Care, Inc. | $27,225 |
| Siemens Medical Solutions USA, Inc. | $26,764 |
| Sumitomo Pharma America, Inc. | $22,225 |
| Med-el Corporation | $19,330 |
| Sanofi US Services Inc. | $17,710 |
| AbbVie | $15,998 |
| Abbott | $14,398 |
| National Marrow Donor Program | $11,085 |
| Novartis | $10,860 |
| AMAG Pharmaceuticals, Inc. | $9,900 |
| Smith+Nephew | $9,675 |
| Purdue Pharma L.p. | $9,120 |
| Agios Pharmaceuticals, Inc. | $8,979 |
| Biomarin Pharmaceutical Inc. | $6,885 |
| Kls-martin L.p. | $5,507 |
| Medtronic | $5,342 |
| Cumberland Pharmaceuticals, Inc. | $5,199 |
| Janssen Research & Development, LLC | $5,100 |
| Eisai Inc. | $5,100 |
| GE HealthCare | $4,564 |
| KARL Storz Endoscopy-america | $4,143 |
| UCB Biosciences Inc. | $2,967 |
| Cochlear Americas | $2,724 |
| Travere Therapeutics, Inc. | $2,522 |
| AstraZeneca | $1,700 |
| Advanced Bionics, LLC | $1,500 |
| BD | $940 |
| Johnson & Johnson | $929 |